Aggravating factors for melasma: A prospective study in 197 Tunisian patients

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 9, 2010, Pages 1060-1069

  Guinot, C ^a,b   Cheffai, S ^c   Latreille, J ^a   Dhaoui, Ma ^c   Youssef, S ^c   Jaber, K ^c   Nageotte, O ^a   Doss, N ^c  

^a CERIES   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Hô Pital Militaire Principal d'Instruction de Tunis ^*  (Tunisia)

Author keywords

aggravating factors; epidemiology; hyperpigmentation; melasma

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; CHLOASMA; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SUN EXPOSURE; TUNISIA;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MELANOSIS; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNISIA;

EID: 77955252809     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03592.x     Document Type: Article

References (31)

1. Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995 131 : 1453 1457.
2. Machado-Pinto J, Borges MF, Magalhães GM. A review of melasma, part 1: etiopathogenic factors, clinical and histopathologic evaluations. Cosmet Dermatol 2006 19 : 683 687.
3. Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. Br J Dermatol 2006 156 : 7 12.
4. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol 2006 54 (Suppl. 2 S272 S281.
5. Cesarini JP. Soleil et peau [Sun and skin]. J Med Esthet 1977 14 : 5 12.
6. Guinot C, Malvy D, Mauger E et al. Self-reported skin sensitivity in a general adult population in France: data of the SU.VI.MAX cohort. J Eur Acad Dermatol Venereol 2006 20 : 380 390.
7. Guinot C, Malvy D, Latreille J et al. Sun exposure behaviour of a general adult population in France. In Ring J, Weidinger S, Darsow U, eds. Skin and Environment - Perception and Protection. Monduzzi, Bologne, 2001 : 1099 1106.
8. Larnier C, Ortonne JP, Venot A et al. Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol 1994 130 : 167 173.
9. Kimbrough-Green CK, Griffiths CE, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994 130 : 727 733.
10. Milton RC. Quantiles. In Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Wiley, Chichester, 1998 : 3628 3629.
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. Wiley, New-York, 1989.
12. Jobson JD. Principal components, factors and correspondence analysis. In Fienberg S, Olkin I, eds. Applied Multivariate Data Analysis. Volume II: Categorical and Multivariate Methods. Dunod, Paris, 1992 : 343 482.
13. Doss N. La phoprotection au Maghreb: us et coutumes. Ann Dermatol Venereol 2002 129 : 1174 1178.
14. Victor FC, Gelber J, Rao B. Melasma: a review. J Cutan Med Surg 2004 8 : 97 102.
15. Hernández-Barrera R, Torres-Alvarez B, Castanedo-Cazares JP et al. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma. Clin Exp Dermatol 2008 33 : 305 308.
16. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001 45 : 1 19.
17. Iraji F. Studying skin changes in 235 pregnant women. Isfahan Med Univ J 1998 54 : 13 17.
18. Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 2006 45 : 285 288.
19. Benchikhi H, Razoki H, Lakhdar H. Sunscreens: use in pregnant woman at Casablanca. Ann Dermatol Venereol 2002 129 : 387 390.
20. Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy. Int J Dermatol 1998 37 : 429 431.
21. Deharo C, Berbis P, Privat Y. Dermatological complications caused by oral contraceptives. Fertil Contracept Sex 1988 16 : 299 304.
22. Zaun H. Skin changes from taking hormonal contraceptives. Med Monatsschr Pharm 1981 4 : 161 165.
23. Ippen H. Clinical aspects of pigmentation disorders due to oral contraceptives. Arch Dermatol Forsch 1972 244 : 500 503.
24. Torres JE, Sanchez JL. Melasma and other disorders of hyperpigmentation. In Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, eds. Cutaneous Medicine and Surgery. W.B. Saunders Co, Philadelphia, 1996 : 1233 1241.
25. White G. Melasma. In Johnson B, Moy R, White GM, eds. Ethnic Skin. Mosby, Baltimore, 1998 : 16 23.
26. Lutfi RJ, Fridmanis M, Misiunas AL et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985 61 : 28 31.
27. Pérez M, Sánchez JL, Aguiló F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 1983 81 : 543 545.
28. Sialy R, Hassan I, Kaur I et al. Melasma in men: a hormonal profile. J Dermatol 2000 27 : 64 65.
29. Vázquez M, Maldonado H, Benmamán C et al. Melasma in men. A clinical and histologic study. Int J Dermatol 1988 27 : 25 27.
30. Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin 2007 25 : 337 342.
31. Schlesselman JJ. Cases-Control Studies. Design, Conduct, Analysis. Oxford University Press, New York, 1982.